Searched for
M.V. RAMANA
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...- Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
- Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition spaceDr Reddy's teams up with Nestle Health Science to introduce Celevida GLP+, a specialized supplement crafted for those navigating the challe...
- Dr Reddy's readies day-1 launch of semaglutide genericDr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and in...
- Dr Reddy’s inks licensing deal to sell Immutep’s cancer drugDr. Reddy's Laboratories has secured an exclusive licensing agreement with Immutep to manufacture, develop, and distribute the Australian c...
- Dr. Reddy's eyes aspirational goal to be in top five in the Indian marketDr. Reddy's Laboratories is prioritizing innovative product launches through strategic partnerships to achieve a 15-16% growth in the India...
- Dr Reddy's launches novel cancer therapy Toripalimab in IndiaDr. Reddy’s has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma ...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Nestle, Dr Reddy's to form JV to market nutraceutical brands in IndiaNestle India and Dr. Reddy’s form a joint venture to introduce new nutraceutical brands in India. The collaboration merges health solutions...
- Dr Reddy's launches migraine management device in EuropeThe launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is ap...
- Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in IndiaDr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The pa...
- Dr Reddy's sells cosmetic derma brands to Eris for Rs 275 crore“India is a focus market for us. We aspire to break into the top 5 in India," said M.V. Ramana, CEO – Branded Markets (India & Emerging Mar...
- SC deliberately flooded with papers to prevent judges from taking up cases: CJI MV RamanaPaperwork despite the court promoting e-filing, and cutting down on insisting on physical copies has always been the bane of the justice de...
- Made in India Sputnik V to be available during September- October: Dr Reddy'sDr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021 af...
- Dr Reddy's forays into nutrition segment; launches diabetic-friendly drinkIt is a first-of-its-kind under Dr Reddy's nutrition portfolio and clinically proven to help manage blood glucose levels among Indian patie...
- Dr Reddy's launches pain relief spray in Indian marketThe spray will be available across the country in two sizes -- pocket pack at Rs 99 and home pack for Rs 130 -- Dr Reddy's Laboratories sai...
- Dr Reddy's picks Alok Sonig to lead North America generics businessIn a top level reshuffle, drug major Dr Reddy's Laboratories appointed Alok Sonig as Executive Vice President & Head for its generics busin...
- Dr Reddy's rejigs top deck as North America head quitsVora will be replaced by Alok Sonig, who is currently responsible for the Indian market and is a member of the management council at the co...
- Gangster Abu Salem convicted in 2001 fake passport caseA special CBI court here convicted extradited gangster Abu Salem in a 2001 fake passport case.
- Dr Reddy's crosses $150 mn revenue in Russia and CIS regionDr Reddy's Laboratories today said that it has crossed the figure of $150 million in revenue in the Russia and CIS region for the fiscal ye...
Load More
